Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Haramburu

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
British Journal of Clinical Pharmacology|May 30, 2008
A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confoundingFleur Grégoire, Antoine Pariente, Annie Fourrier-Reglat, et al.
Presse Medicale (Paris, France : 1983)|June 19, 2007
[Contact dermatitis caused by acetazolamide under occlusion]Amélie Daveluy, Thierry Vial, Laurine Marty, et al.
European Journal of Clinical Pharmacology|March 5, 2015
Preventability of adverse effects of analgesics: analysis of spontaneous reportsIrina Cazacu, Ghada Miremont-Salamé, Cristina Mogosan, et al.
Fundamental & Clinical Pharmacology|July 4, 2014
Incidence of hospital admissions due to adverse drug reactions in France: the EMIR studyAnne Bénard-Laribière, Ghada Miremont-Salamé, Marie-Christine Pérault-Pochat, et al.
Fundamental & Clinical Pharmacology|March 28, 2018
Tamper-resistant prescription forms for narcotics in France: Should we generalize them?Amélie Daveluy, Lucie Sauvaget, Angela Bastien, et al.
American Journal of Clinical Dermatology|February 10, 2010
Cutaneous adverse effects of ketoprofen for topical use: clinical patterns and costsPernelle Noize, Anne Bénard-Laribière, Marine Aulois-Griot, et al.
Drug Safety|June 14, 2011
Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance systemHélène Théophile, Thierry Schaeverbeke, Ghada Miremont-Salamé, et al.
Therapie|August 30, 2020
[Use of synthetic substances in France and in Europe]Danièle Debruyne, Emilie Monzon, Justine Perino, et al.
Pharmacoepidemiology and Drug Safety|July 18, 2006
Peripheral neuropathy associated with leflunomide: is there a risk patient profile?Karin Martin, Fabrice Bentaberry, Chantal Dumoulin, et al.
European Journal of Clinical Pharmacology|December 6, 2005
Surveillance of adverse effects during a vaccination campaign against meningitis CAnne Laribière, Ghada Miremont-Salamé, Hadrien Reyre, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
British Journal of Clinical Pharmacology|May 30, 2008
A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confoundingFleur Grégoire, Antoine Pariente, Annie Fourrier-Reglat, et al.
Presse Medicale (Paris, France : 1983)|June 19, 2007
[Contact dermatitis caused by acetazolamide under occlusion]Amélie Daveluy, Thierry Vial, Laurine Marty, et al.
European Journal of Clinical Pharmacology|March 5, 2015
Preventability of adverse effects of analgesics: analysis of spontaneous reportsIrina Cazacu, Ghada Miremont-Salamé, Cristina Mogosan, et al.
Fundamental & Clinical Pharmacology|July 4, 2014
Incidence of hospital admissions due to adverse drug reactions in France: the EMIR studyAnne Bénard-Laribière, Ghada Miremont-Salamé, Marie-Christine Pérault-Pochat, et al.
Fundamental & Clinical Pharmacology|March 28, 2018
Tamper-resistant prescription forms for narcotics in France: Should we generalize them?Amélie Daveluy, Lucie Sauvaget, Angela Bastien, et al.
American Journal of Clinical Dermatology|February 10, 2010
Cutaneous adverse effects of ketoprofen for topical use: clinical patterns and costsPernelle Noize, Anne Bénard-Laribière, Marine Aulois-Griot, et al.
Drug Safety|June 14, 2011
Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance systemHélène Théophile, Thierry Schaeverbeke, Ghada Miremont-Salamé, et al.
Therapie|August 30, 2020
[Use of synthetic substances in France and in Europe]Danièle Debruyne, Emilie Monzon, Justine Perino, et al.
Pharmacoepidemiology and Drug Safety|July 18, 2006
Peripheral neuropathy associated with leflunomide: is there a risk patient profile?Karin Martin, Fabrice Bentaberry, Chantal Dumoulin, et al.
European Journal of Clinical Pharmacology|December 6, 2005
Surveillance of adverse effects during a vaccination campaign against meningitis CAnne Laribière, Ghada Miremont-Salamé, Hadrien Reyre, et al.
Pageof 7